EUVIMEDEUVIMED entdecken
Open Access

Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19

Sahishnu Patel iD, Alexis Visotcky, Adam Devine iD, Vishwajit Kode iD, Srisha Kotlo iD, Michael Aljadah iD, Rodney Sparapani iD, Jacquelyn Kulinski iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Sahishnu Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Rush University Medical Center Chicago IL USA. Hauptthemen laut MEDLINE: COVID-19, Non-ST Elevated Myocardial Infarction, Hospitalization, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on the incidence of type 2 non–ST‐segment–elevation myocardial infarction (T2MI) in hospitalized patients with COVID‐19 has been limited to single‐center studies. Given that certain characteristics, such as obesity and type 2 diabetes, have been associated with higher mortality in COVID‐19 infections, we aimed to define the incidence of T2MI in a national cohort and identify pre‐hospital patient characteristics associated with T2MI in hospitalized patients with COVID‐19. Methods and Results Using the national American Heart Association COVID‐19 Cardiovascular Disease Quality Improvement Registry, we performed a retrospective 4:1 matched (age, sex, race, and body mass index) analysis of controls versus cases with T2MI. We performed (1) conditional multivariable logistic regression to identify predictive pre‐hospital patient characteristics of T2MI for patients hospitalized with COVID‐19 and (2) stratified proportional hazards regression to investigate the association of T2MI with morbidity and mortality. From January 2020 through May 2021, there were 709 (2.2%) out of 32 015 patients with T2MI. Five hundred seventy‐nine cases with T2MI were matched to 2171 controls (mean age 70; 43% female). Known coronary artery disease, heart failure, chronic kidney disease, hypertension, payor source, and presenting heart rate were associated with higher odds of T2MI. Anti‐hyperglycemic medication and anti‐coagulation use before admission were associated with lower odds of T2MI. Those with T2MI had higher morbidity and mortality (hazard ratio, 1.40 [95% CI, 1.13–1.74]; P =0.002).

Conclusions

In hospitalized patients with COVID‐19, those with a T2MI compared with those without had higher morbidity and mortality. Outpatient anti‐hyperglycemic and anti‐coagulation use were the only pre‐admission factors associated with reduced odds of T2MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Non-ST Elevated Myocardial InfarctionHospitalizationSARS-CoV-2HumansFemaleMaleAgedRetrospective StudiesPrevalenceUnited StatesRisk FactorsMiddle AgedRegistriesIncidenceHospital MortalityAged, 80 and overComorbidity

Stichwörter der Autor:innen

COVID‐19anti‐coagulationanti‐hyperglycemicdemand ischemiaregistrytype 2 NSTEMI

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine Rush University Medical Center Chicago IL USA.
  • Division of Biostatistics Medical College of Wisconsin Milwaukee WI USA.
  • Division of Cardiovascular Medicine University of Minnesota Minneapolis MN USA.
  • Department of Medicine California Pacific Medical Center San Francisco CA USA.
  • Department of Medicine University of Chicago Chicago IL USA.
  • Division of Cardiovascular Medicine Medical College of Wisconsin Milwaukee WI USA.

ORCID-Profile: Sahishnu Patel, Adam Devine, Vishwajit Kode, Srisha Kotlo, Michael Aljadah, Rodney Sparapani, Jacquelyn Kulinski

Zitieren

APA

Patel, S., Visotcky, A., Devine, A., Kode, V., Kotlo, S., Aljadah, M., Sparapani, R., & Kulinski, J. (2024). Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032572

Vancouver

Patel S, Visotcky A, Devine A, Kode V, Kotlo S, Aljadah M, et al. Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032572

BibTeX
@article{Patel2024,
  author = {Patel, Sahishnu and Visotcky, Alexis and Devine, Adam and Kode, Vishwajit and Kotlo, Srisha and Aljadah, Michael and Sparapani, Rodney and Kulinski, Jacquelyn},
  title = {Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032572}
}
Kostenlos starten →